Home › Funds › Bridge City Capital, LLC › PCRX
Bridge City Capital, LLC position in PCRX
PACIRA BIOSCIENCES INC · Health Care
Bridge City Capital, LLC reported holding 352,738 shares of PCRX (PACIRA BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$8.8M, representing 1.84% of its reported portfolio and ranking #11 among its reported holdings. Bridge City Capital, LLC has disclosed PCRX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Bridge City Capital, LLC's PCRX position evolved
Bridge City Capital, LLC first disclosed a stake in PCRX in Q1 2024 at 61,944 shares (US$1.8M). The position peaked in Q1 2026 at 402,765 shares, worth US$9.1M. Across 11 filings, Bridge City Capital, LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 352,738 shares valued at US$8.8M — an increase of 40,441 shares quarter over quarter.. Notable position changes include a 172% increase in Q3 2024 (shares rose 25% over the following quarter), a 84% increase in Q3 2025 (shares were roughly flat over the following quarter), a 41% increase in Q1 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 61.94K | $1.81M | New |
| Q2 2024 | 84.86K | $2.43M | Add |
| Q3 2024 | 231.22K | $3.48M | Add |
| Q4 2024 | 229.20K | $4.32M | Reduce |
| Q1 2025 | 172.15K | $4.28M | Reduce |
| Q2 2025 | 169.67K | $4.06M | Reduce |
| Q3 2025 | 311.44K | $8.03M | Add |
| Q4 2025 | 285.49K | $7.39M | Reduce |
| Q1 2026 | 402.76K | $9.10M | Add |
| Q2 2026 | 312.30K | $7.92M | Reduce |
| Q3 2026 | 352.74K | $8.84M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PCRX and 13F data
PCRX (PACIRA BIOSCIENCES INC) is a Health Care company. 21 other funds we track also report a position in PCRX — the largest reported positions include Context Capital Management, LLC (US$87.0M), Doma Perpetual Capital Management LLC (US$70.5M), GAGNON SECURITIES LLC (US$15.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PCRX
- Context Capital Management, LLC 88.81M sh · $87.01M · Q3 2026
- Doma Perpetual Capital Management LLC 2.78M sh · $70.47M · Q2 2026
- GAGNON SECURITIES LLC 624.80K sh · $15.65M · Q3 2026
More on Bridge City Capital, LLC
FAQ
How long has Bridge City Capital, LLC held PCRX?
Bridge City Capital, LLC has disclosed PCRX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Bridge City Capital, LLC's current position in PCRX?
As of Q3 2026, Bridge City Capital, LLC holds 352.74K shares of PCRX (PACIRA BIOSCIENCES INC), valued at $8.84M, representing 1.84% of its reported portfolio and ranking #11.
Has Bridge City Capital, LLC been buying or selling PCRX?
In the latest 13F filing (Q3 2026), Bridge City Capital, LLC increased its position in PCRX. The position peaked in Q1 2026 at 402.76K shares.
Which other funds hold PCRX?
Other major institutional holders of PCRX include Context Capital Management, LLC, Doma Perpetual Capital Management LLC, GAGNON SECURITIES LLC, among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.